This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia & Upjohn. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Paolo Maranghi: Innovator in Pharmaceutical Compositions
Introduction
Paolo Maranghi is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent related to anthracycline glycosides. His work exemplifies the intersection of chemistry and medicine, aiming to enhance therapeutic efficacy.
Latest Patents
Maranghi holds a patent for "Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation." This patent describes a lyophilized composition that includes a conjugate made from a N-alkyl methacrylamide-based copolymer and an anthracycline glycoside linked through a peptide spacer. The composition may also contain a cosolubilizing agent and optionally a filler. Furthermore, a targeting moiety can be linked to the copolymer of the conjugate via a peptide spacer. An injectable solution of the conjugate is obtained by reconstituting the lyophilized composition. This innovative approach has the potential to improve drug delivery and effectiveness.
Career Highlights
Maranghi is associated with Pharmacia & Upjohn S.p.a., where he has been able to apply his expertise in pharmaceutical sciences. His work has led to advancements in drug formulations, particularly in the area of cancer treatment. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Throughout his career, Maranghi has collaborated with esteemed colleagues such as Marco Adami and Roberto Magrini. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Paolo Maranghi's contributions to pharmaceutical compositions highlight his role as an innovator in the field. His patent on anthracycline glycosides showcases his commitment to improving medical treatments. His work continues to influence the pharmaceutical industry and offers promising advancements in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile